CytoDyn (CYDY) Other Operating Expenses (2010 - 2026)

CytoDyn's Other Operating Expenses history runs 17 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• Quarterly Other Operating Expenses rose 86.93% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $31.0 million (up 253.65% YoY) and the FY2025 annual result came in at -$16.9 million, changed N/A from the prior year.
• Other Operating Expenses was $4.6 million for Q1 2026 at CytoDyn, down from $19.9 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $64.7 million in Q2 2022 and bottomed at -$24.0 million in Q3 2024.
• A 5-year average of $6.0 million and a median of $2.5 million in 2025 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 240560.0% — and 2025, when it jumped 35428.57%.
• CytoDyn's Other Operating Expenses stood at $18.0 million in 2022, then slumped by 99.96% to $8000.0 in 2023, then surged by 17512.5% to $1.4 million in 2024, then surged by 1311.57% to $19.9 million in 2025, then sank by 76.63% to $4.6 million in 2026.
• Business Quant data shows CYDY's Other Operating Expenses at $4.6 million in Q1 2026, $19.9 million in Q4 2025, and $3.2 million in Q3 2025.